JOSHUA ELLSWORTH: Open Payments
NPI 1073167821 · ENID, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$559 in 31 payments from 9 companies in 2025. Trend: 2023 $480 · 2024 $435 · 2025 $559
Food & beverage: $559
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 8 | $151 |
| AstraZeneca Pharmaceuticals LP | 7 | $119 |
| ABBVIE INC. | 5 | $92 |
| Lilly USA, LLC | 3 | $50 |
| Exact Sciences Corporation | 3 | $47 |
| Supernus Pharmaceuticals, Inc. | 2 | $41 |
| Vanda Pharmaceuticals Inc. | 1 | $27 |
| Gilead Sciences, Inc. | 1 | $16 |
| Viatris Specialty LLC | 1 | $16 |
Products named: REXULTI, BREZTRI, MOUNJARO, Cologuard Collection Kit, AIRSUPRA, Qelbree, UBRELVY, FANAPT.
Industry payments across OK — which companies pay providers there.
